Harbarth, Stephan
University Hospital of Geneva
9 papers on CoChatORCID 0000-0002-3551-1025
Most cited papers
- Verified
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases
Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria
Cited by 6,142
- Verified
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
Pittet, D., Hugonnet, S., Harbarth, S., Mourouga, P., Sauvan, V., Touveneau, S., & Perneger, T. V. (2000) · The Lancet
Infection Control in HealthcareNosocomial Infections in ICU
Cited by 2,524
- Verified
Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe
Köck, R., Becker, K., Cookson, B., van Gemert-Pijnen, J. E., Harbarth, S., Kluytmans, J., Mielke, M., Peters, G., Skov, R. L., Struelens, M. J., et al. (2010) · Eurosurveillance
Antimicrobial Resistance in StaphylococcusAntibiotic Use and Resistance
Cited by 611
- Verified
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action
Carlet, J., Jarlier, V., Harbarth, S., Voss, A., Goossens, H., Pittet, D., & Forum, T. P. O. T. 3. W. H.-A. I. (2012) · Antimicrobial Resistance and Infection Control
Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria
Cited by 350
- Verified
Effect of C-Reactive Protein–Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
von Dach, E., Albrich, W. C., Brunel, A.-S., Prendki, V., Cuvelier, C., Flury, D., Gayet-Ageron, A., Huttner, B., Kohler, P., Lemmenmeier, E., et al. (2020) · JAMA
Antibiotic Use and ResistanceSepsis Diagnosis and Treatment
Cited by 259
- Verified
Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: A prospective observational multi-center study.
Bloos, F., Thomas-Rüddel, D., Rüddel, H., Engel, C., Schwarzkopf, D., Marshall, J. C., Harbarth, S., Simon, P., Riessen, R., Keh, D., et al. (2014) · Critical Care
Sepsis Diagnosis and TreatmentAbdominal Surgery and Complications
Cited by 240
- Verified
Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: A cluster randomized trial.
for the MEDUSA study group, Bloos, F., Rüddel, H., Thomas-Rüddel, D., Schwarzkopf, D., Pausch, C., Harbarth, S., Schreiber, T., Gründling, M., Marshall, J., et al. (2017) · Intensive Care Medicine
Sepsis Diagnosis and TreatmentHealth Policy Implementation Science
Cited by 200
- Verified
Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group
Schweitzer, V. A., van Werkhoven, C. H., Rodríguez Baño, J., Bielicki, J., Harbarth, S., Hulscher, M., Huttner, B., Islam, J., Little, P., Pulcini, C., et al. (2020) · Clinical Microbiology and Infection
Antibiotic Use and ResistanceHealth Policy Implementation Science
Cited by 73
- Verified
Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review
Abbas, M., Pires, D., Peters, A., Morel, C. M., Hurst, S., Holmes, A., Saito, H., Allegranzi, B., Lucet, J.-C., Zingg, W., et al. (2018) · Intensive Care Medicine
Pharmaceutical industry and healthcareAcademic integrity and plagiarism
Cited by 17
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free